匹可硫酸钠，CAS 登记号 10040-45-6，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于无机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
无机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 匹可硫酸钠 的 CAS 号：10040-45-6，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及无机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Sodium picosulfate · CAS 10040-45-6 · C18H13NNa2O8S2. UNII VW106606Y8.
| CAS Registry Number | 10040-45-6 |
|---|---|
| PubChem CID | 68654 |
| Molecular formula | C18H13NNa2O8S2 |
| IUPAC name | disodium;[4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] sulfate |
| UNII (FDA) | VW106606Y8 |
| Molecular Weight | 481.4 |
|---|---|
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 480.98779728 |
| Monoisotopic Mass | 480.98779728 |
| Topological Polar Surface Area | 163 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 633 |
| GHS notification summary | 66.7% (2 / 3) |
|---|
| GHS notification summary | 66.7% (2 / 3) |
|---|---|
| Reported hazard statements | H302 (33.3%), H315 (33.3%), H319 (33.3%), H335 (33.3%) |
This chemical does not meet GHS hazard criteria for 66.7% (2 of 3) of all reports.
H302 (33.3%): Harmful if swallowed [Warning Acute toxicity, oral]
sodium picosulfate; 10040-45-6; Picosulfate sodium; Laxoberon; Neopax; Laxoberal; Sodium picosulphate; Guttalax-Fher; Pico-Salax; Picosulfate de sodium; Natrii picosulfas; Picosulfato sodico; Sodium picosulphate anhydrous; DA-1773; DTXSID7048663; Picosulfate sodium anhydrous
CAS 10040-45-6; molecular formula C18H13NNa2O8S2; molecular weight — g/mol.
sodium picosulfate, 10040-45-6, Picosulfate sodium, Laxoberon, Neopax, Laxoberal.
66.7% of GHS notifications report no hazard classification (2 of 3).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.